Variant report
Variant | esv3692789 |
---|---|
Chromosome Location | chr3:83554093-83561127 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537124374 | chr3:83560609-83560610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550632298 | chr3:83560623-83560624 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs550249451 | chr3:83560639-83560640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539012447 | chr3:83560641-83560642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182272766 | chr3:83560642-83560643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187473324 | chr3:83560673-83560674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370378835 | chr3:83560674-83560675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554662410 | chr3:83560675-83560676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs375232402 | chr3:83560689-83560690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs75209897 | chr3:83560719-83560720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543495326 | chr3:83560738-83560739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4605563 | chr3:83560788-83560789 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs577164736 | chr3:83560843-83560844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545790189 | chr3:83560863-83560864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540235839 | chr3:83560867-83560868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563995532 | chr3:83560883-83560884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs9839870 | chr3:83560933-83560934 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs375366436 | chr3:83560939-83560940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189612908 | chr3:83560943-83560944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561851852 | chr3:83560962-83560963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371484676 | chr3:83560998-83560999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs75332295 | chr3:83561005-83561006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs114593313 | chr3:83561008-83561009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182216326 | chr3:83561033-83561034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116734506 | chr3:83561035-83561036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539375889 | chr3:83561105-83561106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs71616486 | chr3:83561110-83561111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200734137 | chr3:83561112-83561113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs75739725 | chr3:83561117-83561118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs77176204 | chr3:83561121-83561122 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs375397964 | chr3:83561126-83561127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs2318135 | chr3:83561127-83561128 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Melanoma | 18172304 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Wilms tumour | 21544195 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Medulloblastoma | 16783165 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Mental retardation | 17124404 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:83560600-83560800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr3:83560800-83564200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |